BioNTech SE (BNTX)
96.90
+0.05
(+0.05%)
USD |
NASDAQ |
Oct 02, 16:00
96.90
0.00 (0.00%)
After-Hours: 20:00
BioNTech Price to Book Value : 1.199 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.199 |
| October 01, 2026 | 1.198 |
| September 30, 2026 | 1.216 |
| September 29, 2026 | 1.220 |
| September 28, 2026 | 1.226 |
| September 25, 2026 | 1.219 |
| September 24, 2026 | 1.228 |
| September 23, 2026 | 1.218 |
| September 22, 2026 | 1.248 |
| September 21, 2026 | 1.213 |
| September 18, 2026 | 1.189 |
| September 17, 2026 | 1.221 |
| September 16, 2026 | 1.186 |
| September 15, 2026 | 1.196 |
| September 14, 2026 | 1.223 |
| September 11, 2026 | 1.197 |
| September 10, 2026 | 1.193 |
| September 09, 2026 | 1.214 |
| September 08, 2026 | 1.221 |
| September 04, 2026 | 1.284 |
| September 03, 2026 | 1.273 |
| September 02, 2026 | 1.284 |
| September 01, 2026 | 1.261 |
| August 31, 2026 | 1.257 |
| August 28, 2026 | 1.263 |
| Date | Value |
|---|---|
| August 27, 2026 | 1.378 |
| August 26, 2026 | 1.393 |
| August 25, 2026 | 1.411 |
| August 24, 2026 | 1.396 |
| August 21, 2026 | 1.442 |
| August 20, 2026 | 1.372 |
| August 19, 2026 | 1.400 |
| August 18, 2026 | 1.148 |
| August 17, 2026 | 1.133 |
| August 14, 2026 | 1.152 |
| August 13, 2026 | 1.140 |
| August 12, 2026 | 1.148 |
| August 11, 2026 | 1.148 |
| August 10, 2026 | 1.148 |
| August 07, 2026 | 1.159 |
| August 06, 2026 | 1.128 |
| August 05, 2026 | 1.141 |
| August 04, 2026 | 1.130 |
| August 03, 2026 | 1.141 |
| July 31, 2026 | 1.121 |
| July 30, 2026 | 1.149 |
| July 29, 2026 | 1.150 |
| July 28, 2026 | 1.144 |
| July 27, 2026 | 1.127 |
| July 24, 2026 | 1.105 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 11.21 |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 2.116 |
| NuCana Plc | 29.07 |
| MediGene AG | -- |
Price to Book Value Related Metrics
| PS Ratio | 7.754 |
| PEG Ratio | -0.0316 |
| Price to Free Cash Flow | 56.50 |
| Price | 96.90 |
| Earnings Yield | -8.10% |
| Market Cap | 24.34B |
| PEGY Ratio | -0.0316 |